Why the Immutep (ASX:IMM) share price is on watch today

The Immutep Ltd (ASX: IMM) share price is on watch as the company announced a significant upscale to its manufacturing capacity.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Immutep Ltd (ASX: IMM) share price is on watch this morning on news the company will significantly upscale its manufacturing capacity.

The Immutep share price finished Wednesday's trading session at 43 cents, up 6.1%.

Immutep is a biotech company focused on the development of LAG-3 immunotherapeutic products for cancer and autoimmune diseases.

What did Immutep announce?

In today's release, Immutep advised it will begin ramping up the manufacture its lead product candidate, eftilagimod alpha, otherwise known as efti or IMP321.

The decision to increase production follows the company's positive interim results from its efti clinical trials.

Immutep will expand its efti manufacturing process from 200 litres to a proposed 2,000 litre bioreactor capability. The WuXi Biologics plant in China will house production of the soluble LAG-3 protein, which is expected to scale up throughout 2021.

Although management did not specify the cost involved, it said a recent conversion of warrants will fund the strategic move.

CEO commentary

Commenting on the progress, Immutep CEO Marc Voigt said:

Following the very encouraging interim Overall Survival data announced last week from our largest clinical trial, AIPAC, we have activated our plans to upscale the manufacturing of efti to 2,000L single-use bioreactors to prepare for potential commercial manufacturing and potential registration trials in multiple indications.

WuXi Biologics is an important and long-term partner for us with excellent technical and commercial capabilities. We are entering 2021 in a very strong position, both financially and operationally.

About the Immutep share price

The Immutep share price has soared recently, reaching 63 cents just a few days ago. While its shares have pulled back around 31%, the company is still up 40% from 1 month ago.

Immutep has grown from an ASX micro-cap share to a now small-cap share, with a market capitalisation of $211.9 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Broker Notes

Guess which ASX 300 stock was downgraded to sell today

Bell Potter has become bearish on this stock. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX gave up an afternoon lead to close lower today.

Read more »

a gas worker with hard hat and high visibility vest stands cross armed and smiling in front of an elaborate steel structured gas plant.
Share Market News

Morgans names 2 ASX energy shares to buy now

These shares could be top picks for investors with a high tolerance for risk.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Broker Notes

Is the ResMed share price still cheap? What the numbers say

Let's see what analysts are saying about this blue chip as it nears a 52-week high.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Broker Notes

What does Macquarie think REA shares are worth?

Top broker Macquarie has reviewed its rating and price target on REA shares.

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Aurelia Metals, Centuria Office, Meeka Metals, and Resolute shares are tumbling today

These shares are having a tough time on Thursday. Let's find out why.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

These shares are pushing higher on Thursday. But why?

Read more »

Woman checking out new TVs.
Broker Notes

Does JP Morgan think JB Hi-Fi shares can keep rising?

The retailer is up 16% for the year to date.

Read more »